Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County

Pharmacogenetics

Volumn 7, Issue 5, 1997, Pages 401-404

  London, Stephanie J ^a   Sullivan Klose, Theresa ^a,b   Daly, Ann K ^c   Idle, Jeffrey R ^d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Institute for Cancer Research   (Norway)

Author keywords

CYP2C; Cytochrome P4502C; Cytochrome P4502C9; Epidemiology; Susceptibility

Indexed keywords

CYTOCHROME P450;

CAUCASIAN; ETHNOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; PRIORITY JOURNAL; RISK; SHORT SURVEY; SMOKING; UNITED STATES;

ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LOS ANGELES; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES;

EID: 0030773244     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199710000-00010     Document Type: Short Survey

References (9)

1. Bauer E, Guo Z, Ueng Y, Bell LC, Zeldin D, Guengerich FP. Oxidation of benzo[α]pyrene by recombinant human cytochrome P450 enzymes. Chem Res Toxicol 1995: 8, 136-142.
2. Bhasker CR, Miners JO, Coulter S, Birkett DJ. Allelic and functional variability of cytochrome P4502C9. Pharmacogenetics 1997, 7, 51-58.
3. Degawa M, Stern S, Marin MV, Guengerich FP, Fu PP, Ilett KF, Kaderlik RK, Kadulbar FF. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res 1994, 54, 4915-4919.
4. Furuya H, Fernandez-Salguero P, Gregory W, Taber H, Steward A, Gonzalez FJ, Idle JR. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy. Pharmacogenetics 1995: 5, 389-392.
5. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995: 87, 1246-1253.
6. London SJ, Daly AK, Leathart JBS, Navidi WC, Idle JR. Lung cancer risk in relation to CYP2C9*1/CYP2C9*2 genetic polymorphisms among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 1996: 6, 527-533.
7. 144C allelic variant of CYP2C9. Pharmacogenetics 1994: 4, 39-42.
8. Sullivan-Klose TH, Ghanayem BI, Bell DA, Zhang Z, Kaminsky LS, Shenfield GM, Miners JO, Birkett DJ, Goldstein JA. The role of the CYP2C9-Leu 359 allelic variant in the tolbutamine polymorphism. Pharmacogenetics. 1996: 6, 341-350.
9. Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[α]pyrene and benzo[α]pyrene trans-7, 8-dihydrodiol. Mol Carcinogen 1994: 10, 159-168.